Masahito Uemura

2.8k total citations
66 papers, 2.1k citations indexed

About

Masahito Uemura is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Masahito Uemura has authored 66 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 25 papers in Epidemiology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Masahito Uemura's work include Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (20 papers) and Alcohol Consumption and Health Effects (15 papers). Masahito Uemura is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Liver Disease and Transplantation (20 papers) and Alcohol Consumption and Health Effects (15 papers). Masahito Uemura collaborates with scholars based in Japan, Germany and United States. Masahito Uemura's co-authors include Hiroshi Fukui, Hideyuki Kojima, Hitoshi Yoshiji, Tatsuhiro Tsujimoto, Masao Fujimoto, Masanori Matsumoto, Yoshihiro Fujimura, Mitsuteru Kitade, Shinya Sakurai and Ryuichi Noguchi and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Masahito Uemura

64 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahito Uemura Japan 28 899 746 476 335 304 66 2.1k
H. E. Abboud United States 29 478 0.5× 644 0.9× 344 0.7× 1.1k 3.3× 427 1.4× 52 3.1k
Aileen Dela Peňa Australia 12 639 0.7× 290 0.4× 182 0.4× 359 1.1× 253 0.8× 14 1.3k
Junichi Yoshii Japan 25 1.0k 1.1× 1.2k 1.6× 153 0.3× 915 2.7× 301 1.0× 42 2.7k
Yasuhide Ikenaka Japan 27 1.1k 1.3× 1.3k 1.7× 158 0.3× 896 2.7× 330 1.1× 55 2.9k
Eitaro Taniguchi Japan 27 1.1k 1.2× 1.2k 1.6× 115 0.2× 832 2.5× 420 1.4× 66 2.9k
Koji Yanase Japan 22 632 0.7× 686 0.9× 86 0.2× 479 1.4× 186 0.6× 38 1.6k
Masahito Minami Japan 33 1.8k 2.0× 1.4k 1.9× 176 0.4× 577 1.7× 291 1.0× 71 2.8k
Kosuke Kaji Japan 27 1.1k 1.3× 902 1.2× 146 0.3× 786 2.3× 452 1.5× 126 2.5k
David McCarey United Kingdom 10 340 0.4× 174 0.2× 806 1.7× 497 1.5× 592 1.9× 14 3.1k
Alessandra Gentilini Italy 20 1.1k 1.3× 1.3k 1.7× 144 0.3× 578 1.7× 570 1.9× 34 2.3k

Countries citing papers authored by Masahito Uemura

Since Specialization
Citations

This map shows the geographic impact of Masahito Uemura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahito Uemura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahito Uemura more than expected).

Fields of papers citing papers by Masahito Uemura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahito Uemura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahito Uemura. The network helps show where Masahito Uemura may publish in the future.

Co-authorship network of co-authors of Masahito Uemura

This figure shows the co-authorship network connecting the top 25 collaborators of Masahito Uemura. A scholar is included among the top collaborators of Masahito Uemura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahito Uemura. Masahito Uemura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Masanori, Norio Kurumatani, Ayami Isonishi, et al.. (2014). Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions. Blood. 124(21). 4209–4209. 2 indexed citations
2.
Yoshiji, Hitoshi, Ryuichi Noguchi, Tadashi Namisaki, et al.. (2013). Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance. Oncology Reports. 30(2). 545–552. 16 indexed citations
3.
Kawaratani, Hideto, et al.. (2011). Therapeutic effects of cytokine modulator Y‐40138 in the rat alcoholic liver disease model. Journal of Gastroenterology and Hepatology. 26(4). 775–783. 16 indexed citations
4.
Kasai, Takahiko, et al.. (2009). Non-alcoholic steatohepatitis in Nara Medical University Hospital between 2003 and 2008; retrospective study with clinicopathologic analysis.. 60(5). 149–158. 1 indexed citations
5.
Kitade, Mitsuteru, Hitoshi Yoshiji, Ryuichi Noguchi, et al.. (2009). Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis. World Journal of Gastroenterology. 15(41). 5193–5193. 37 indexed citations
6.
Yoshiji, Hitoshi, Ryuichi Noguchi, Mitsuteru Kitade, et al.. (2009). Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats. Journal of Gastroenterology. 44(5). 483–491. 54 indexed citations
7.
Yoshiji, Hitoshi, Ryuichi Noguchi, Masahisa Toyohara, et al.. (2009). Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. Journal of Hepatology. 51(2). 315–321. 76 indexed citations
8.
Kawaratani, Hideto, Tatsuhiro Tsujimoto, Mitsuteru Kitade, et al.. (2008). Innate immune reactivity of the liver in rats fed a cholinedeficient L-amino-acid-defined diet. World Journal of Gastroenterology. 14(43). 6655–6655. 35 indexed citations
9.
Ishikawa, Masatoshi, Masahito Uemura, Tomomi Matsuyama, et al.. (2008). Potential Role of Enhanced Cytokinemia and Plasma Inhibitor on the Decreased Activity of Plasma ADAMTS13 in Patients With Alcoholic Hepatitis: Relationship to Endotoxemia. Alcoholism Clinical and Experimental Research. 34(s1). S25–33. 28 indexed citations
10.
Ishikawa, Masatoshi, Tatsuhiro Tsujimoto, Masahito Uemura, et al.. (2007). [A case of intrahepatic splenosis].. PubMed. 104(12). 1758–65. 2 indexed citations
11.
Kojima, Hideyuki, et al.. (2007). Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases. Journal of Gastroenterology and Hepatology. 23(7pt2). e120–8. 35 indexed citations
12.
Kojima, Hideyuki, Shingo Okamoto, Hitoshi Yoshiji, et al.. (2006). Glucocorticoid Therapy Ameliorated Hypoglycemia in Insulin-like Growth Factor-II-producing Solitary Fibrous Tumor. Internal Medicine. 45(8). 525–529. 40 indexed citations
13.
Ko, Saiho, Hiromichi Kanehiro, Masanori Matsumoto, et al.. (2006). Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: Observations in 3 cases. Liver Transplantation. 12(5). 859–869. 32 indexed citations
14.
15.
Uemura, Masahito, Kouko Tatsumi, Masanori Matsumoto, et al.. (2005). Localization of ADAMTS13 to the stellate cells of human liver. Blood. 106(3). 922–924. 231 indexed citations
16.
Kojima, Hideyuki, Anne T. Nies, Jörg König, et al.. (2003). Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. Journal of Hepatology. 39(5). 693–702. 135 indexed citations
17.
Kojima, Hideyuki, Masahito Uemura, Shinya Sakurai, et al.. (2002). Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. Journal of Gastroenterology. 37(8). 617–625. 38 indexed citations
18.
Uemura, Masahito, Wolf‐Dieter Lehmann, Helmut K. Seitz, et al.. (2000). Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication. Gastroenterology. 118(6). 1140–1148. 8 indexed citations
19.
20.
Uemura, Masahito, Ulrike Buchholz, Hideyuki Kojima, et al.. (1994). Cysteinyl Leukotrienes in the Urine of Patients With Liver Diseases. Hepatology. 20(4). 804–812. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. E. Abboud Breakdown of academic impact, for papers by Aileen Dela Peňa Breakdown of academic impact, for papers by Junichi Yoshii Breakdown of academic impact, for papers by Yasuhide Ikenaka Breakdown of academic impact, for papers by Eitaro Taniguchi Breakdown of academic impact, for papers by Koji Yanase Breakdown of academic impact, for papers by Masahito Minami Breakdown of academic impact, for papers by Kosuke Kaji Breakdown of academic impact, for papers by David McCarey Breakdown of academic impact, for papers by Alessandra Gentilini
Rankless by CCL
2026